Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Boitard

Showing results (211-220 of 217) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 217 results.
The New England Journal of Medicine|March 17, 1988
Factors associated with early remission of type I diabetes in children treated with cyclosporineP F Bougneres, J C Carel, L Castano, et al.
Eneuro|June 6, 2017
Impact of Early Consumption of High-Fat Diet on the Mesolimbic Dopaminergic SystemF Naneix, F Tantot, C Glangetas, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2006
Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agentsR Eldor, A Yeffet, K Baum, et al.
Lancet (London, England)|August 19, 2000
Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale groupL Chaillous, H Lefèvre, C Thivolet, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Breast inflammatory gigantomastia in a context of immune-mediated diseasesP Touraine, N Youssef, M A Alyanakian, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation InitiativeR Mallone, M Scotto, C N Janicki, et al.
Diabetologia|April 25, 2012
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patientsM Scotto, G Afonso, E Larger, et al.
Pageof 22

Showing results (211-220 of 217) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 217 results.
The New England Journal of Medicine|March 17, 1988
Factors associated with early remission of type I diabetes in children treated with cyclosporineP F Bougneres, J C Carel, L Castano, et al.
Eneuro|June 6, 2017
Impact of Early Consumption of High-Fat Diet on the Mesolimbic Dopaminergic SystemF Naneix, F Tantot, C Glangetas, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2006
Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agentsR Eldor, A Yeffet, K Baum, et al.
Lancet (London, England)|August 19, 2000
Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale groupL Chaillous, H Lefèvre, C Thivolet, et al.
The Journal of Clinical Endocrinology and Metabolism|June 24, 2005
Breast inflammatory gigantomastia in a context of immune-mediated diseasesP Touraine, N Youssef, M A Alyanakian, et al.
Diabetes/Metabolism Research and Reviews|November 10, 2011
Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation InitiativeR Mallone, M Scotto, C N Janicki, et al.
Diabetologia|April 25, 2012
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patientsM Scotto, G Afonso, E Larger, et al.
Pageof 22